Hemo-rheologic changes following treatment with human recombinant erythropoietin in chronic hemodialysis patients
Melappioni, M.; Giansanti, R.; Boemi, M.; Baldassari, M.; Baldini, S.; Pierangeli, T.; Radicioni, R.; Fumelli, P.; Panichi, N.
Minerva Urologica e Nefrologica 44(2): 155-159
1992
ISSN/ISBN: 0393-2249 PMID: 1411871 Document Number: 394831
Document emailed within 1 workday
Related Documents
Moynot, A.; Zins, B.; Naret, C.; Canaud, B.; Polito, C.; Judith, D.; Poisson, D.; Cavalli, I.; Jacquot, C.; Drüeke, T. 1990: One-year treatment of 43 chronic hemodialysis patients with recombinant human erythropoietin Presse Medicale 19(3): 111-115Jacquot, C.; Berthelot, J.M.; Chiappini-Judith, D.; Ferragu-Haguet, M.; Lefebvre, A.; Masselot, J.P.; Moynot, A.; Frydman, M.O.; Peterlongo, F. 1990: Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients Nephrologie 11(1): 11-16
Imamura, Y.; Hase, H. 1991: Effect of recombinant human erythropoietin (rEPO) on angina pectoris in patients with chronic maintenance hemodialysis Nihon Jinzo Gakkai Shi 33(4): 403-408
Boratyńska, M.; Szewczyk, Z.; Szepietowski, T.; Czyz, W.; Cybulski, K.; Bogucki, J.; Szczepański, J. 1990: Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis Przeglad Lekarski 47(11): 741-745
Zehnder, C.; Blumberg, A. 1989: Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis Clinical Nephrology 31(2): 55-59
Rud'ko, I.A.; Balashova, T.S.; Pokrovskiĭ, I.A.; Ermolenko, V.M.; Kubatiev, A.A. 1993: The effect of human recombinant erythropoietin on the lipid peroxidation processes and antioxidant protection of the erythrocytes in patients with chronic kidney failure on hemodialysis Gematologiia i Transfuziologiia 38(3): 24-26
Hou, C.C.; Wu, S.C.; Wu, S.C.; Yang, W.C.; Huang, T.P.; Ng, Y.Y. 1998: Serum transferrin receptor concentration is not indicative of erythropoietic activity in chronic hemodialysis patients with poor response to recombinant human erythropoietin Zhonghua Yi Xue Za Zhi 61(8): 456-462
Laupacis, A. 1991: A randomized double-blind study of recombinant human erythropoietin in anaemic hemodialysis patients. Canadian Erythropoietin Study Group Transplantation Proceedings 23(2): 1825-1826
Tsai, J.C.; Lai, Y.H.; Tsai, Z.Y.; Chien, L.J.; Tsai, J.H. 1991: Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum Gaoxiong Yi Xue Ke Xue Za Zhi 7(3): 126-135
Mohini, R. 1989: Clinical efficacy of recombinant human erythropoietin in hemodialysis patients Seminars in Nephrology 9(1 Suppl 1: 16-21
Fialon, P.; Leaute, A.G.; Sassier, P.; Vallot, C.; Wone, C. 1993: Use of red blood cell indices (MCV, MCH, RDW) in monitoring chronic hemodialysis patients treated with recombinant erythropoietin Pathologie-Biologie 41(10): 931-935
Acharya, V.N.; Sinha, D.K.; Almeida, A.F.; Pathare, A.V. 1995: Effect of low dose recombinant human omega erythropoietin (rHuEPO) on anaemia in patients on hemodialysis Journal of the Association of Physicians of India 43(8): 539-542
Riedel, E.; Hampl, H.; Scigalla, P.; Nündel, M.; Kessel, M. 1989: Correction of amino acid metabolism by recombinant human erythropoietin therapy in hemodialysis patients Kidney International. Supplement 27: S216-S221
Trakarnvanich, T.; Thitiarcharkul, S. 2004: Comparison between intravenous recombinant human erythropoietin and subcutaneous injection in Thai hemodialysis patients Journal of the Medical Association of Thailand 87(9): 1041-1047
Ksiazek, A.; Baranowska-Daca, E. 1993: Hematocrit influence on peritoneal dialysis effectiveness during recombinant human erythropoietin treatment in patients with chronic renal failure Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 13(Suppl 2): S550-S552
Kukhtevich, A.V.; Ermolenko, V.M.; Dedov, I.I.; Gitel', E.P.; Buniatian, A.F.; Smirnova, G.A. 1992: The comparative characteristics of parlodel, zinc sulfate and recombinant erythropoietin in treating uremic hypogonadism in patients on chronic hemodialysis Terapevticheskii Arkhiv 64(11): 66-70
Takayama, K. 1993: Changes in endothelial vasoactive substances and blood coagulation and fibrinolysis functions under recombinant human erythropoietin therapy in hemodialysis patients Nihon Jinzo Gakkai Shi 35(2): 179-188
Agroyannis, B.; Koutsicos, D.; Tzanatou-Exarchou, H.; Varsou-Papadimitriou, E.; Kapetanaki, A.; Yatzidis, H. 1991: Combined recombinant human erythropoietin-blood letting strategy for treating anemia and iron overload in hemodialysis patients International Journal of Artificial Organs 14(7): 403-406
Kulzer, P.; Schaefer, R.M.; Krahn, R.; Schaefer, L.; Heidland, A. 1994: Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group International Journal of Artificial Organs 17(4): 195-202
Rozental', R.L.; Zezina, L.Iu.; Spudass, A.V. 1991: The use of recombinant erythropoietin with patients on programmed hemodialysis Terapevticheskii Arkhiv 63(12): 110-113